The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,974.00
Bid: 1,974.00
Ask: 1,975.00
Change: 14.00 (0.71%)
Spread: 1.00 (0.051%)
Open: 1,994.00
High: 2,000.00
Low: 1,959.00
Prev. Close: 1,960.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET CLOSE: BoE Stimuli Push Up Stocks But Depress Sterling

Thu, 04th Aug 2016 16:04

LONDON (Alliance News) - Stocks in London ended firmly in the green Thursday, while the pound took a big hit, after the Bank of England announced a substantial package of stimuli including an interest rate cut to a new record low and an expansion in asset purchases, after recent macroeconomic data had pointed to a slowdown in the UK economy following the Brexit referendum.

The BoE also drastically downgraded its growth projections as the Leave vote heightened uncertainty and the sharp depreciation in sterling triggered an upward revision to the inflation forecast.

The Monetary Policy Committee voted unanimously to cut UK interest rates by 25 basis points to 0.25%, the first rate cut since 2009. Governor Mark Carney said in a press conference following the decision that there is room for further cuts to rates, but made it clear that they will not go as low as to become negative.

"I'm not a fan of negative rate interest rates," Carney said, speaking to journalists. The governor signalled that the lower bound of rates will be close to zero, but always "a positive number".

Alongside the cut to rates, the central bank expanded the size of its Asset Purchase Facility programme, with the increase totalling GBP170 billion as a whole. Purchases of UK government bonds will increase by GBP60 billion to GBP435 billion. This measure was passed after the MPC voted 6-3, with policymakers Kristin Forbes, Ian McCafferty, and Martin Weale against the proposition, preferring no change.

The MPC also decided on the purchase of up to GBP10 billion of UK corporate bonds, with the decision approved with 8-1 majority.

In addition, the MPC voted unanimously to introduce a Term Funding Scheme that will be financed by the issuance of central bank reserves, aimed to help reinforce the transmission of the interest rate cut to the real economy. The BoE said this will operate as part of the asset purchasing programme.

The value of the lending in the TFS will be determined by usage of the scheme, the bank said, and could reach "around GBP100 billion". Carney added that UK banks have "no excuse" not to pass on the rate cut.

The governor said that, at this meeting, "everyone in the MPC though this economy needed stimulus". Carney noted that the Leave vote in the referendum represents a "regime change", but said the UK is "one of the most flexible economies in the world".

Oanda senior market analyst Craig Erlam said that, with this decision, "the BoE became one of the only central banks to announce a stimulus package that appears to have, at least for now, exceeded market expectations and satisfy investors in a way that other central banks have failed this year."

According to the Inflation Report released alongside the monetary policy decision, the economy is likely to see little growth in the second half of 2016. Business investment is set to continue to fall in the near term on slower demand growth. Gross domestic product growth is forecast to ease to 0.1% in the third quarter of 2016. The bank slashed its GDP growth outlook for 2017 to 0.8% from 2.3%. Similarly, the projection for 2018 was trimmed to 1.8% from 2.3%.

The fall in sterling is set to push up inflation in the near-term. Inflation is forecast to return to the 2% target in late 2017 and overshoot this target throughout 2018.

Sterling dropped immediately after the BoE's decision, having being quoted at USD1.3316 just prior. At the London equities close, the pound stood at 1.3138, compared to USD1.3327 at the same time Wednesday. The currency, however, remained way above the 31-year low of USD1.2797 reached in early July, with the results of the EU referendum still fresh.

Contrary to the pound, London stocks shot higher after the BoE decision, with the FTSE 100 index ending up 1.6%, or 105.76 points, at 6,740.16. The FTSE 250 of mid-caps rose 1.5%, or 247.19 points, to 17,244.32, and the AIM All-Share added 0.6%, or 4.33 points, to end at 761.66.

Aviva ended as the biggest blue-chip gainer, up 6.7%. The insurer's chief executive told journalists he is unsure about what an interest rate cut in the UK will achieve, after the blue-chip insurer had posted higher operating profit and hiked its dividend on a strong first half for its life and fund management businesses.

Aviva CEO Mark Wilson, speaking before the BoE's decision, said there is not currently a large amount of household debt in the UK and borrowing rates are already "incredibly cheap". Wilson was sanguine when questioned about any impact Aviva could face from interest rates remaining low or, indeed, falling further.

He said Aviva has been structured to ensure liabilities and assets move together, adding the group has "deliberately positioned" itself as a "blue-chip haven" against low interest rates.

Aviva declared an interim dividend of 7.42p, up from 6.75p a year prior, driven by strong performances in its life insurance and fund management operations. It said it remains on track to deliver on its plan to increase its dividend payout ratio to 50% of operating earnings per share by the end of 2017 from 42% in 2015.

RSA Insurance also reported first-half results, delivering a big rise in underwriting profit and declaring an increase in dividend. Underwriting profit for the first half increased 63% to GBP119.0 million from GBP73.0 million. This was driven by a 3.1 percentage point improvement in RSA's attritional loss ratio to 54.8% from 57.9%. The group declared an interim dividend of 5.0 pence per share, up 43% from 3.5p a year prior. RSA shares rose 1.4%.

Shares in Standard Chartered added 4.3% after Standard & Poor's Global upgraded the lender to Hold from Sell, while HSBC Holdings rose 2.5% after Merrill Lynch lifted its recommendation on the bank to Buy from Underperform, according to traders.

Hikma Pharmaceuticals missed the gains, ending as by far the worst blue-chip performer, down 17%. The drug company late Wednesday said it expects full-year operating profit within its Generics division to be hit by changes in revenue mix, but maintained its guidance on its other two divisions.

The company noted that it had experienced some delays in certain product approvals, but said the impact to revenue should be offset by higher contract manufacturing revenue. However, Hikma said the change in revenue mix is expected to hit profitability in 2016, along with higher than expected costs resulting from the acceleration in timing of certain pipeline-related litigation.

Hikma said it now expects core operating profit within its Generics division to come in within the range of USD30.0 million and USD40.0 million for 2016, below the USD46.0 million reported for 2015. Hikma was downgraded to Neutral from Buy by Citigroup and to Hold from Add by Numis.

In mainland Europe, the CAC 40 index in Paris the DAX 30 in Frankfurt both added 0.6%. At the equities close, the euro was quoted at USD1.1134, compared to USD1.1175 at the same time Wednesday.

In New York, stocks were higher at the European equities close, with the Dow 30 flat, and the S&P and the Nasdaq Composite both up 0.1%.

Gold was quoted at USD1.363.19 an ounce at the equities close, against USD1,357.14 on Wednesday, while Brent oil stood at USD43.30 a barrel, compared to USD42.47 on Wednesday.

Highlights in the economic calendar Friday are UK Halifax house prices at 0830 BST, and US nonfarm payrolls at 1330 BST. The US Baker Hughes US oil rig count is at 1800 BST.

In the UK corporate calendar, Royal Bank of Scotland Group, Ibstock, William Hill, Esure Group, and Kennedy Wilson Europe Real Estate all report half-year results. Bellway and S&U issue trading statements.

By Daniel Ruiz; danielruiz@alliancenews.com

Copyright 2016 Alliance News Limited. All Rights Reserved.

More News
24 May 2022 07:09

Hikma's Siggi Olafsson stands down as CEO

(Sharecast News) - Drugmaker Hikma Pharmaceuticals revealed on Tuesday that chief executive Siggi Olafsson has resigned from both the role and the company's board of directors in order to pursue other opportunities.

Read more
13 May 2022 16:01

UK shareholder meetings calendar - next 7 days

Monday 16 May 
88 Energy LtdAGM
Allianz Technology Trust PLCAGM
Blackbird PLCAGM
BSF Enterprise PLCGM
Crossword Cybersecurity PLCAGM
DigitalBox PLCAGM
Ethernity Networks LtdAGM
Jubilee Metals Group PLCGM - re right of directors to allot equity securities for cash
Mast Energy Developments PLCAGM
Metal Tiger PLCAGM
Tuesday 17 May 
Accesso Technology Group PLCAGM
Capital & Regional PLCAGM
Chaarat Gold Holdings LtdAGM
Chesnara PLCAGM
Equals Group PLCAGM
European Assets Trust PLCAGM
Fidelity Japan Trust PLCAGM
Fintel PLCAGM
Fresnillo PLCAGM
GCP Asset Backed Income Fund LtdAGM
GENinCode PLCFull Year Results
Greggs PLCAGM
IQGeo Group PLCAGM
Kefi Gold & Copper PLCGM re share placing
Mears Group PLCAGM
Mercantile Investment Trust PLCAGM
Vitec Group PLCAGM
Vivo Energy PLCAGM
Wednesday 18 May  
ABCAM PLCAGM
abrdn PLCAGM in Edinburgh
Alliance Pharma PLCAGM
Burford Capital LtdAGM
Coats Group PLCAGM
CVC Credit Partners European Opportunities LtdAGM
EKF Diagnostics Holdings PLCAGM
Highcroft Investments PLCAGM
Impax Environmental Markets PLCAGM
JPMorgan American Investment Trust PLCAGM
Keller Group PLCAGM
LMS Capital PLCAGM
Merchants Trust PLCAGM
PensionBee Group PLCAGM
Permanent TSB Group Holdings PLCAGM
PYX Resources LtdAGM
Riverstone Credit Opportunities Income PLCAGM
Schroder UK Public Private Trust PLCAGM
Science Group PLCAGM
Seplat Energy PLCAGM
TI Fluid Systems PLCAGM
Vesuvius PLCAGM
Thursday 19 May  
Bigblu Broadband PLCAGM
Brand Architekts Group PLCGM re takeover of InnovaDerma
Capital & Regional PLCAGM
Computacenter PLCAGM
Cornish Metals IncGM re equity raise
Dialight PLCAGM
Ebiquity PLCAGM
Eqtec PLCAGM
Essentra PLCAGM
Fevertree Drinks PLCAGM
Gamma Communications PLCAGM
Genuit Group PLCAGM
Headlam Group PLCAGM
Inchcape PLCAGM
InnovaDerma PLCGM re takeover by Brand Architekts
Irish Residential Properties REIT PLCAGM
K3 Business Technology Group PLCAGM
Light Science Tech Holdings PLCAGM
Live Co Group PLCGM
McColl's Retail Group PLCAGM
musicMagpie PLCAGM
Network International Holdings PLCAGM
Next PLCAGM
Pharos Energy PLCAGM
Property Franchise Group PLCAGM
Rotala PLCAGM
Smart Metering Systems PLCAGM
St James's Place PLCAGM
Tyman PLCAGM
Friday 20 May  
Bank of Cyprus Holdings PLCAGM
Croda International PLCAGM
Deliveroo PLCAGM
Georgia Capital PLCAGM
Hikma Pharmaceuticals PLCEGM re capital reduction
Keywords Studios PLCAGM
Real Estate Investors PLCAGM
Reckitt Benckiser Group PLCAGM
Resolute Mining LtdAGM
Restore PLCAGM
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
6 May 2022 09:47

LONDON BROKER RATINGS: Downgrades for Centrica and Rathbones

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

Read more
5 May 2022 12:11

LONDON MARKET MIDDAY: Pound slips as BoE opts for quarter-point hike

(Alliance News) - Stock prices in London were higher, while the pound was flat, on Thursday, after the Bank of England as expected raised UK interest rates by a quarter percentage point.

Read more
5 May 2022 10:51

Signs of slowdown on the continent

Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.com

SIGNS OF SLOWDOWN ON THE CONTINENT (1051 GMT)

Read more
5 May 2022 09:24

TOP NEWS: Hikma shares fall 10% on delay to Jazz Pharmaceuticals drug

(Alliance News) - Shares in Hikma Pharmaceuticals PLC fell early Thursday, after the drugmaker downgraded guidance for its Generics business due to the delayed launch of a generic of the Xyrem treatment for narcolepsy.

Read more
5 May 2022 08:58

LONDON MARKET OPEN: Mondi and Shell lift FTSE 100 after strong updates

(Alliance News) - Stock prices in London opened sharply higher on Thursday after the US Federal reserve assuaged fears over further aggressive monetary policy tightening, while positive updates from Mondi and Shell boosted the FTSE 100.

Read more
5 May 2022 08:02

Hikma cuts 2022 generics guidance due to drug launch delay

(Sharecast News) - Hikma Pharmaceuticals cut guidance for its generics business on Thursday, citing a delay to a drug launch.

Read more
29 Apr 2022 17:44

IN BRIEF: Hikma says has not entered license agreement with Opiant

Hikma Pharmaceuticals PLC - London-based generic drugmaker - Confirms that it has not entered into any transaction with Opiant Pharmaceutical UK, following a PR Newswire announcement issued on Friday. The release said Opiant and Hikma entered into a commercialisation and license agreement for OPNT003, Nasal Nalmefene, in Europe and the UK.

Read more
29 Apr 2022 17:01

LONDON MARKET CLOSE: Stocks end volatile April on high note

(Alliance News) - Stocks in London on Friday ended a volatile month of April in a positive fashion, amid a continued rush of company earnings, while markets in the US sank as high-profile tech names disappointed.

Read more
29 Apr 2022 09:09

Hikma Pharmaceuticals notes "slow" start for Generics business in 2022

(Alliance News) - Hikma Pharmaceuticals PLC said on Friday that both its Injectables and Branded businesses have performed well at the start of the year but noted its Generics business has experienced some headwinds.

Read more
29 Apr 2022 08:32

Hikma shares fall as generics unit faces headwinds

(Sharecast News) - Hikma Pharmaceuticals shares fell as the company reported headwinds at its generics business.

Read more
29 Apr 2022 08:25

LONDON BRIEFING: Pearson has positive first quarter, buys language app

(Alliance News) - Educational materials publisher Pearson on Friday provided a positive update on first quarter trading, while also announcing a new acquisition.

Read more
21 Apr 2022 16:06

UK dividends calendar - next 7 days

Friday 22 April 
JPMorgan Global Emerging Markets Income Trust PLCdividend payment date
Henderson Eurotrust PLCdividend payment date
Monday 25 April 
abrdn Smaller Cos Income Trust PLCdividend payment date
Tuesday 26 April 
Anglo American PLCdividend payment date
Anglo American PLCspecial dividend payment date
Invesco Asia Trust PLCdividend payment date
Wednesday 27 April 
Close Brothers Group PLCdividend payment date
Thursday 28 April 
4imprint Group PLCex-dividend date
AEW UK REIT PLCex-dividend date
AVI Japan Opportunity Trust PLCex-dividend date
Bakkavor Group PLCex-dividend date
Carr's Group PLCex-dividend date
Coats Group PLCex-dividend date
CQS Natural Resources Growth & Income PLCex-dividend date
CQS New City High Yield Fund Ltdex-dividend date
Derwent London PLCex-dividend date
Drax Group PLCex-dividend date
Ecofin Global Utilities & Infrastructure Trust PLCex-dividend date
Fresnillo PLCex-dividend date
Henderson Far East Income Trust PLCex-dividend date
Hikma Pharmaceuticals PLCdividend payment date
HSBC Holdings PLCdividend payment date
Kenmare Resourcesex-dividend date
LSL Property Services PLCex-dividend date
M&G PLCdividend payment date
M P Evans Group PLCex-dividend date
Mobius Investment Trust PLCex-dividend date
Morgan Advanced Materials PLCex-dividend date
Morgan Sindall Group PLCex-dividend date
Mortgage Advice Bureau (Holdings) PLCex-dividend date
Northamber plcdividend payment date
Porvair PLCex-dividend date
Reckitt Benckiser Group PLCex-dividend date
Rightmove PLCex-dividend date
Sabre Insurance Group PLCex-dividend date
Sabre Insurance Group PLCspecial ex-dividend date
Schroder Oriental Income Fund Ltdex-dividend date
Secure Income REIT PLCex-dividend date
Smart Metering Systems PLCdividend payment date
St James's Place PLCex-dividend date
Synthomer PLCex-dividend date
Tate & Lyle PLCspecial ex-dividend date
TT Electronics PLCex-dividend date
Tyman PLCex-dividend date
XP Power Ltddividend payment date
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
21 Apr 2022 14:37

IN BRIEF: Hikma Pharmaceuticals completes Custopharm deal

Hikma Pharmaceuticals PLC - London-based generic drugmaker - Completes acquisition of Custopharm Inc from Water Street Healthcare Partners, following approval from the US Federal Trade Commission. Back in September, Hikma agreed to buy the California-based generic injectable products company for a total of up to USD425 million. Deal will add up to 13 approved products and additional pipeline products.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.